OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2025
(6)
2023
(4)
2022
(4)
2026
(1)
2020
(1)
2019
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Design and Implementation of a One Health Framework for Evaluating the Transmission Potential of Pathogens of Public Health Interest for Surveillance Studies.
Not available
S-EPMC12631772
|
biostudies-literature
Cite
ViMOP: a user-friendly and field-applicable pipeline for untargeted viral genome nanopore sequencing.
Not available
S-EPMC12809542
|
biostudies-literature
Cite
Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria.
Not available
S-EPMC7200043
|
biostudies-literature
Cite
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria.
Not available
S-EPMC9907520
|
biostudies-literature
Cite
High Burden of Coinfections With Epidemic-Prone Pathogens Among Febrile Patients in Nigeria: A Multi-Pathogen Surveillance Study.
Not available
S-EPMC12631764
|
biostudies-literature
Cite
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.
Not available
S-EPMC8769305
|
biostudies-literature
Cite
Epidemiology of Plasmodium spp. Detection Among Acute Febrile Illness Patients in Two Regions of Nigeria.
Not available
S-EPMC12631765
|
biostudies-literature
Cite
Descriptive Epidemiology of Acute Febrile Illness Patients in Nigeria: Pathogens of Global Public Health Significance Detected Using a Multi-Pathogen Detection Tool.
Not available
S-EPMC12631784
|
biostudies-literature
Cite
Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics.
Not available
S-EPMC11845141
|
biostudies-literature
Cite
COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria.
Not available
S-EPMC10022313
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets